Centre for Commercialization of Regenerative Medicine
Registration:
1
of
7
(2021-12-15
to
2022-03-02)
Grant, Contribution or Other Financial Benefit
- Seeking funding from the Strategic Innovation Fund to allow the client to expand regenerative cell and gene therapy manufacturing in Ontario.